Register entry

Lonza Bend Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
4
Labeller names
2
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

4

4 active NDC listings: 4 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 4.

Dosage formNDCs
powder3
granule1
RouteNDCs
Labeller name on the listingNDCs
lonza bend inc3
lonza bend inc.1
Catalogue

Marketed products

4
BrandGeneric nameForm / routeNDC
-Apremilastpowder87222-009DRUG FOR FURTHER PROCESSING
-Selumetinibgranule87222-010DRUG FOR FURTHER PROCESSING
-enzalutamidepowder87222-001DRUG FOR FURTHER PROCESSING
-lonafarnibpowder87222-002DRUG FOR FURTHER PROCESSING
Compare

Other companies listing apremilast

Enquiry

Common questions

Is Lonza Bend Inc. FDA approved?
Lonza Bend Inc. holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Lonza Bend Inc. make?
4 products are listed under Lonza Bend Inc. in the openFDA NDC Directory, most often as powder; granule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.